TCG Crossover Management, LLC
- SEC CIK
- 0001839948
- Latest filing
- Aug 14, 2026
Holdings in Q2 2022
Holdings as of Jun 30, 2022, filed Aug 15, 2022. Long positions only; changes compare share counts with Q1 2022.
- Positions
- 22
- +2 vs. Q1 2022
- Portfolio value
- $235.4M
- −$13.7M (−5.5%) vs. Q1 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| COGTCogent Biosciences, Inc. | COM | 3,481,042 | $31.4M | 13.3% | +500,000+16.8% | Added | History |
| ISEEIVERIC bio, Inc. | COM | 2,914,250 | $28.0M | 11.9% | +397,330+15.8% | Added | History |
| GERNGeron Corp | COM | 15,096,342 | $23.4M | 9.9% | +810,627+5.7% | Added | History |
| KURAKura Oncology, Inc. | COM | 1,167,642 | $21.4M | 9.1% | +661,219+130.6% | Added | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 5,905,400 | $17.4M | 7.4% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 1,144,939 | $16.0M | 6.8% | 00.0% | Unchanged | History |
| VRDNViridian Therapeutics, Inc. | COM | 1,314,000 | $15.2M | 6.5% | 00.0% | Unchanged | History |
| KDNYChinook Therapeutics, Inc. | COM | 796,460 | $13.9M | 5.9% | −85,893−9.7% | Reduced | History |
| JBIOJade Biosciences, Inc. | COM | 889,572 | $13.9M | 5.9% | 00.0% | Unchanged | History |
| TRDAEntrada Therapeutics, Inc. | COM | 663,694 | $8.08M | 3.4% | 00.0% | Unchanged | History |
| MRUSMerus N.V. | COM | 300,000 | $6.79M | 2.9% | 00.0% | Unchanged | History |
| TYRATyra Biosciences, Inc. | COM | 896,418 | $6.41M | 2.7% | 00.0% | Unchanged | History |
| AKUSAkouos, Inc. | COM | 1,350,006 | $6.33M | 2.7% | 00.0% | Unchanged | History |
| TNGXTango Therapeutics, Inc. | COM | 1,172,250 | $5.31M | 2.3% | −82,250−6.6% | Reduced | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 1,000,000 | $5.25M | 2.2% | +1,000,000 | New | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 578,260 | $4.92M | 2.1% | −455,962−44.1% | Reduced | History |
| ETNB89bio, Inc. | COM | 1,133,196 | $3.65M | 1.6% | +1,133,196 | New | History |
| ZLABZai Lab Ltd | ADR | 95,000 | $3.29M | 1.4% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,124,122 | $2.55M | 1.1% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 58,515 | $1.19M | 0.5% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 555,000 | $777.0K | 0.3% | 00.0% | Unchanged | History |
| PRDSPardes Biosciences, Inc. | COM | 59,039 | $181.0K | 0.1% | −170,061−74.2% | Reduced | History |